Similar articles for PMID: 22116992

Year	Number of Results
1927	1
1950	1
1953	1
1978	1
1979	2
1981	4
1983	4
1984	4
1985	1
1987	1
1989	1
1990	1
1992	4
1993	3
1994	6
1995	2
1996	2
1997	3
1998	2
1999	5
2000	3
2001	3
2002	5
2003	5
2004	3
2005	1
2006	4
2007	2
2008	7
2009	1
2010	3
2011	7
2012	10
2013	5
2014	11
2015	9
2016	9
2017	9
2018	6
2019	6
2020	8
2021	9
2022	7
2023	3
2024	1

1

A US perspective of symptomatic Latrodectus spp. envenomation and treatment: a National Poison Data System review.

Monte AA, Bucher-Bartelson B, Heard KJ. Monte AA, et al. Ann Pharmacother. 2011 Dec;45(12):1491-8. doi: 10.1345/aph.1Q424. Epub 2011 Nov 24. Ann Pharmacother. 2011. PMID: 22116992 Review.

2

Black widow spider (Latrodectus mactans) antivenom in clinical practice.

Monte AA. Monte AA. Curr Pharm Biotechnol. 2012 Aug;13(10):1935-9. doi: 10.2174/138920112802273335. Curr Pharm Biotechnol. 2012. PMID: 22352727 Review.

3

Treatment of pediatric black widow spider envenomation: A national poison center's experience.

Glatstein M, Carbell G, Scolnik D, Rimon A, Hoyte C. Glatstein M, et al. Am J Emerg Med. 2018 Jun;36(6):998-1002. doi: 10.1016/j.ajem.2017.11.011. Epub 2017 Nov 6. Am J Emerg Med. 2018. PMID: 29133072

4

Examination of adverse events following black widow antivenom use in California.

Nordt SP, Clark RF, Lee A, Berk K, Lee Cantrell F. Nordt SP, et al. Clin Toxicol (Phila). 2012 Jan;50(1):70-3. doi: 10.3109/15563650.2011.639714. Epub 2011 Dec 19. Clin Toxicol (Phila). 2012. PMID: 22175789

5

Anaphylaxis to black widow spider antivenom.

Hoyte CO, Cushing TA, Heard KJ. Hoyte CO, et al. Am J Emerg Med. 2012 Jun;30(5):836.e1-2. doi: 10.1016/j.ajem.2011.03.017. Am J Emerg Med. 2012. PMID: 21641165

6

The Efficacy of Antivenin Latrodectus (Black Widow) Equine Immune F(ab')₂ Versus Placebo in the Treatment of Latrodectism: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.

Dart RC, Bush SP, Heard K, Arnold TC, Sutter M, Campagne D, Holstege CP, Seifert SA, Lo JCY, Quan D, Borron S, Meurer DA, Burnham RI, McNally J, Garcia-Ubbelohde W, Anderson VE. Dart RC, et al. Ann Emerg Med. 2019 Sep;74(3):439-449. doi: 10.1016/j.annemergmed.2019.02.007. Epub 2019 Mar 27. Ann Emerg Med. 2019. PMID: 30926190 Clinical Trial.

7

Red-back spider (Latrodectus hasselti) antivenom prevents the toxicity of widow spider venoms.

Graudins A, Padula M, Broady K, Nicholson GM. Graudins A, et al. Ann Emerg Med. 2001 Feb;37(2):154-60. doi: 10.1067/mem.2001.113033. Ann Emerg Med. 2001. PMID: 11174232

8

Latrodectus geometricus (Aranea: Theridiidae) envenoming: Rapid resolution of symptoms following F(ab')₂ antivenom therapy.

Keyler DE, Ahmad M, Rodriguez A, De Silva PMK. Keyler DE, et al. Toxicon. 2020 Dec;188:76-79. doi: 10.1016/j.toxicon.2020.10.009. Epub 2020 Oct 14. Toxicon. 2020. PMID: 33068558

9

Clinical presentation and treatment of black widow spider envenomation: a review of 163 cases.

Clark RF, Wethern-Kestner S, Vance MV, Gerkin R. Clark RF, et al. Ann Emerg Med. 1992 Jul;21(7):782-7. doi: 10.1016/s0196-0644(05)81021-2. Ann Emerg Med. 1992. PMID: 1351707

10

Clinical and in vitro evidence for the efficacy of Australian red-back spider (Latrodectus hasselti) antivenom in the treatment of envenomation by a Cupboard spider (Steatoda grossa).

Graudins A, Gunja N, Broady KW, Nicholson GM. Graudins A, et al. Toxicon. 2002 Jun;40(6):767-75. doi: 10.1016/s0041-0101(01)00280-x. Toxicon. 2002. PMID: 12175614

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

169 results

Results by year